Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: For those that are wondering were the rest of our cut is...its in Q2

For those that are wondering were the rest of our cut is...its in Q2

posted on Oct 23, 2006 03:36PM
From the 10Q; During the three months ended August 31, 2006, Phoenix Digital entered into licensing agreements with third parties, pursuant to which it received aggregate proceeds of $25,749,000. During September 2006 Phoenix Digital entered into licensing agreements pursuant to which it received aggregate proceeds of $6,950,000 Also I believe we received $31.6M from Fujitsu not $33.6 as someone stated earlier. As far as Q1 is concerned the top line numbers look reasonable (little on the low end though) with the exception of Sony which is difficult to determine because management wont let us in on what the "strategic" reason was for letting them off the hook. Was it strategic for legal purposes? Was it strategic for product purposes? Was it only strategic to TPL or is it strategic for Patriot as well? I'm not sure why management cannot address this in general terms so investors can make a decision on their investment. Without any guidance from management on this issue we are back to wishful thinking yet again. I do realize that TPL probably put a muzzle on us once again.

Oct 23, 2006 04:22PM

Oct 23, 2006 06:14PM
Share
New Message
Please login to post a reply